Caprion-HistoGeneX Expands its Histological Biomarker Franchise by Joining Forces with Mosaic Laboratories (1)

MONTREAL, Jan.12, 2021 / PRNewswire / – Caprion-HistoGeneX, a leading global provider of contract research laboratory services backed by Arsenal Capital Partners (“Arsenal”), today announced the acquisition of Mosaic Laboratories LLC (“Mosaic “), a California-based company that provides histology and immunohistochemistry services to global pharmaceutical clients. The addition of Mosaic further strengthens the North American foundation for the development and deployment of Caprion-HistoGeneX histopathology assays, expands the volume of pathology services, and consolidates the company’s position as the world’s leading provider of histopathology biomarker analysis services. for global clinical trials.… [… ]… […]

Mosaic is a pioneer in the use of multiplex immunohistochemistry with spectral imaging and is recognized for its outstanding services for the development, validation and implementation of complex immunohistochemistry, in situ hybridization and FISH assays, positioning itself as one of the most prominent and comprehensive providers in the world. field. Mosaic’s core capabilities include study design, trial development and implementation, data interpretation, and services to support exploratory biomarker analysis in preclinical and clinical trial stages, enabling timely decisions for patient selection.

“We are truly excited to join forces with Caprion-HistoGeneX. This partnership offers strong collaborative opportunities that will further support our clients’ programs and allow us to globalize our existing and future trials to support clinical trials,” said Chris Kerfoot and Lisa Dauffenbach. , co-founders and board members of Mosaic.

“The combination of Mosaic and Caprion-HistoGeneX strengthens our leadership position as a global provider of precision medicine services offering the full range of immunohistochemistry, immune monitoring, proteomics biomarkers and genomics,” said Martin LeBlanc, CEO of Caprion- HistoGeneX. “Mosaic’s excellent track record in developing and implementing complex immunohistochemical assays will enhance our ability to meet the rapidly expanding needs of our clients for histopathology services in our global network of laboratories in North America, Europe and Asia, including China. “

“The addition of Mosaic reflects Arsenal’s commitment to support the development and international expansion of Caprion-HistoGeneX through continued investment in complementary capabilities, services and geographic coverage, and consolidates the company’s leadership position in one of the fastest growing areas of biopharmaceutical R&D, “said David Spaight, CEO of Caprion-HistoGeneX and operating partner of Arsenal.

In conjunction with this transaction and the recently announced acquisition of Clinical Logistics Inc., Caprion-HistoGeneX also plans to unveil its new corporate name and brand identity to the combined entities in the coming weeks that reflect its vision and positioning as a leading global provider. precision medicine services.

Kirkland & Ellis LLP acted as legal advisors to Caprion-HistoGeneX.

Intrepid Investment Bankers LLC acted as financial advisers, and Davis Wright Tremaine LLP acted as legal advisor to Mosaic.

About Caprion-HistoGeneX Caprion-HistoGeneX is a leading provider of specialized precision medicine laboratory services for the biopharmaceutical industry. Leveraging its integrated analytical platforms in immunology, histopathology, proteomics and genomics, as well as related sample collection and logistics services, Caprion-HistoGeneX supports the entire drug development cycle, from discovery to late-stage clinical trials. The company operates globally with 9 facilities located in Canada, the US, Belgium, Australia and China. For more information: […] and […]

About Mosaic Laboratories LLCMosaic is a leader in providing preclinical and clinical services to the pharmaceutical industry and has pioneered multiplex chromogenic immunohistochemistry using multispectral imaging. Mosaic develops proprietary assays, tissue banks, and software algorithms to support data analysis. Leveraging this durable and highly differentiated multiplex IHC experience, Mosaic has built a reputation for having the highest quality validated assays, vivid multiplex IHC imaging, and rapid development and implementation of new assays, backed by an uncompromising service approach in speed, agility and customer service. The company has also developed a broader menu of core laboratory services, including histology, FISH, and ISH. For more information: […]

About Arsenal Capital PartnersArsenal is a leading private equity firm specializing in investments in mid-market healthcare and industrial companies. Since its inception in 2000, Arsenal has raised institutional capital investment funds of $ 5.3 billion, completed more than 200 investments in platforms and add-ons, and achieved more than 30 accomplishments. Arsenal invests in industrial sectors in which the firm has significant prior knowledge and experience. The firm works with management teams to build strategically important companies with leading market positions, high growth, and high added value. For more information: […].

CONTACT: Caprion-HistoGeneX: Guylaine Galipeau, Director of Global Marketing, Caprion-HistoGeneX,[] ; Arsenal Capital Partners: Prosek Partners, Brian Schaffer / Kristen Duarte,[] /[]


Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.